The relationship between productivity and health-related QOL Werner B. F. BrouwerWillem-Jan MeerdingJohan L. Severens Current Opinion 17 September 2012 Pages: 209 - 218
Penny and pound wise Mike F. van OostenbruggenRonald B. JansenHuib Kooijman Current Opinion 17 September 2012 Pages: 219 - 226
The economic impact of neuropsychiatric symptoms in Alzheimer’s disease Daniel L. MurmanChristopher C. Colenda Leading Article 17 September 2012 Pages: 227 - 242
International variation in resource utilisation and treatment costs for rheumatoid arthritis Hubertus RoseryRito BergemannStefanie Maxion-Bergemann Review Article 17 September 2012 Pages: 243 - 257
Oral serotonin receptor agonists Jennifer H. LoflandDavid B. Nash Review Article 17 September 2012 Pages: 259 - 274
A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain Pedro J. Tárraga-LópezÁngel Celada-RodríguezJaime De Miguel-Clave Original Research Article 17 September 2012 Pages: 275 - 287
The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis Jan SørensenLis S. Andersen Original Research Article 17 September 2012 Pages: 289 - 298
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US Natalie C. EdwardsMarcia F. T. RupnowRonald J. Diamond Original Research Article 17 September 2012 Pages: 299 - 314